Editor-in-chief
Prof. Parsons Xuejun Huang
Department of Regenerative Medicine, USA
Director
Molecular Cancer Therapeutics program, Cancer institute
University of Mississippi Medical Center
United States of America
Dr. Wael M ElShamy is a Director of Molecular Cancer Therapeutics program, Cancer institute, University of Mississippi Medical Center. He is also an Associate Professor in the Department of Radiation Oncology and Pathology at University of Mississippi Medical Center, USA. Dr. ElShamy's received his Ph.D. in Medical Biochemistry and Biophysics from Royal Karolinska Institute, Stockholm, Sweden. Dr. Wael M ElShamy’ s research interest encompass basic, clinical and translational cancer research. Research programs in his laboratory and program focus on identifying and improve treatments for breast and ovarian cancers, especially metastatic diseases, development of novel drug delivery techniques and identifying diagnostic as well as prognostic molecular biomarkers for these diseases. In his laboratory, the main focus is identifying the earliest disease lesions, and the development of targeted therapies for cancer stem cells.
